Association of Hormonal Contraception with Meningioma Location in Indonesian Patients

Malueka, Rusdy Ghazali; Hartanto, Rahmat Andi; Setyawan, Nurhuda Hendra; Fauzi, Dyajeng Noor Firdaus; Damarjati, Khoironi Rachmad; Rismawan, Alfian; Septianastiti, Maria Alethea; Wicaksono, Adiguno Suryo; Dananjoyo, Kusumo; Basuki, Endro; Asmedi, Ahmad; Dwianingsih, Ery Kus

doi:10.31557/APJCP.2022.23.3.1047

Association of Hormonal Contraception with Meningioma Location in Indonesian Patients

Document Type : Research Articles

Authors

¹ Neurology Department, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia.

² Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia.

³ Department of Radiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia.

⁴ Department of Anatomical Pathology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia.

10.31557/APJCP.2022.23.3.1047

Abstract

Background: Meningioma is the most common primary intracranial tumor. Previous studies have shown the possible association between hormonal contraceptive use and meningioma location. Therefore, this study aimed to analyze the association between the history of hormonal contraceptive use and the location of meningioma in the Indonesian population. Methods: In total, 99 histologically confirmed female meningioma patients admitted to Dr. Sardjito General Hospital Yogyakarta, Indonesia, were included in this study. Data on hormonal contraception and other variables were collected from medical records. Meningioma locations were determined from brain Magnetic Resonance Imaging (MRI) or Computerized Tomography (CT) scan before surgery. Results: Seventy-two (72.7%) patients had a history of hormonal contraceptive use. The subjects consist of 83 (83.8%) WHO grade I and 16 (16.2%) WHO grade II and III tumors. A total of 57 (57.6%) tumors were located in the spheno-orbital region. We found a significant association between hormonal contraceptive use and meningioma location in the spheno-orbital region (Odds ratio (OR) 2.573, p=0.038). This resulted in the patients in the hormonal contraception group having more visual impairment (p=0.044). Conclusion: The use of hormonal contraception is associated with the location of meningioma in the spheno-orbital region.

Keywords

Main Subjects